(Q51992463)

19 April 2018

review article

1 reference

title

Organizational guidelines for dual disorders programs. (English)

1 reference

19 April 2018

author name string

C C Mercer

series ordinal

1

1 reference

19 April 2018

K T Mueser

series ordinal

2

1 reference

19 April 2018

R E Drake

series ordinal

3

1 reference

19 April 2018

publication date

1 January 1998

1 reference

19 April 2018

published in

Psychiatric Quarterly

1 reference

19 April 2018

volume

69

1 reference

19 April 2018

issue

3

1 reference

19 April 2018

page(s)

145-168

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1023/a:1022145125499

exact match

0 references

cites work

THE MULTIPLE READMISSION PSYCHIATRIC PATIENT.

1 reference

12 December 2020

Consumers as service providers: the promise and challenge

1 reference

12 December 2020

Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital.

1 reference

12 December 2020

Recent psychostimulant use in hospitalized schizophrenics

1 reference

12 December 2020

Alcohol use and abuse in schizophrenia. A prospective community study

1 reference

12 December 2020

Detection of substance use disorders in severely mentally ill patients

1 reference

12 December 2020

Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach

1 reference

12 December 2020

Co-occurring disorders among mentally ill jail detainees: Implications for public policy

1 reference

12 December 2020

The Young Adult Chronic Patient: Overview of a Population

1 reference

12 December 2020

A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.

1 reference

12 December 2020

Rehabilitative day treatment vs. supported employment: I. Vocational outcomes.

1 reference

12 December 2020

Comparison of DSM-III-R diagnoses and a brief interview for substance use among state hospital patients

1 reference

12 December 2020

Drug and alcohol dependence and psychiatric populations: the need for diagnosis, intervention, and training

1 reference

12 December 2020

Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care

1 reference

12 December 2020

Treatment of patients with psychiatric and psychoactive substance abuse disorders

1 reference

12 December 2020

Family costs associated with severe mental illness and substance use.

1 reference

12 December 2020

Substance use disorders in a sample of Canadian patients with chronic mental illness

1 reference

12 December 2020

The course, treatment, and outcome of substance disorder in persons with severe mental illness

1 reference

12 December 2020

The role of inpatient care for patients with co-occurring severe mental disorder and substance use disorder.

1 reference

12 December 2020

Substance abuse among general psychiatric patients: place of presentation, diagnosis, and treatment

1 reference

12 December 2020

Expenditures of time and money by families of people with severe mental illness and substance use disorders

1 reference

12 December 2020

History of drug abuse and dangerous behavior in inpatient schizophrenics

1 reference

12 December 2020

Substance abuse and family relationships of persons with severe mental illness.

1 reference

12 December 2020

Prevalence and patterns of "dual diagnosis" among psychiatric inpatients

1 reference

12 December 2020

Dual diagnosis of major mental illness and substance disorder: an overview

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

1 reference

12 December 2020

Substance abuse by young adult chronic patients.

1 reference

12 December 2020

Diagnosis of alcohol use disorders in schizophrenia

1 reference

12 December 2020

Barriers to the care of persons with dual diagnoses: organizational and financing issues

1 reference

12 December 2020

Correlates and outcomes of alcohol use disorder among rural outpatients with schizophrenia.

1 reference

12 December 2020

Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia

1 reference

12 December 2020

Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.

1 reference

12 December 2020

Characteristic hostility in schizophrenic outpatients

1 reference

12 December 2020

Substance abuse in schizophrenia: service utilization and costs

1 reference

12 December 2020

Missed diagnosis of substance abuse in psychiatric patients.

1 reference

12 December 2020

Characteristics and Treatment of Homeless, Mentally Ill, Chemical-Abusing Men

1 reference

12 December 2020

Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.

1 reference

12 December 2020

An integrated treatment model for dual diagnosis of psychosis and addiction.

1 reference

12 December 2020

Factors associated with risk for HIV infection among chronic mentally ill adults

1 reference

12 December 2020

Young adult chronic patients: an analytical review of the literature

1 reference

12 December 2020

An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults.

1 reference

12 December 2020

HIV seroprevalence among patients admitted to two psychiatric hospitals

1 reference

12 December 2020

The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders

1 reference

12 December 2020

A pilot study of residential treatment for dual diagnoses

1 reference

12 December 2020

The new chronic patient and the system of community care.

1 reference

12 December 2020

Effects of illicit drug use in an inpatient psychiatric population.

1 reference

12 December 2020

Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.

1 reference

12 December 2020

Drug abuse in schizophrenia

1 reference

12 December 2020

Substance abuse among the chronic mentally ill.

1 reference

12 December 2020

Clinical case management of the dually diagnosed patient

1 reference

12 December 2020

Urine drug screening of patients admitted to a state psychiatric hospital.

1 reference

12 December 2020

Individual Placement and Support: a community mental health center approach to vocational rehabilitation

1 reference

12 December 2020

Continuous treatment teams in the care of the chronic mentally ill

1 reference

12 December 2020

Treatment of alcoholism among schizophrenic outpatients: 4-year outcomes.

1 reference

12 December 2020

Assessing the evidence of a link between mental illness and violence.

1 reference

12 December 2020

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders

1 reference

12 December 2020

Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports

1 reference

12 December 2020

Problem drinking in hospitalized schizophrenic patients.

1 reference

12 December 2020

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

1 reference

12 December 2020

Treatment of substance abuse in severely mentally ill patients.

1 reference

12 December 2020

Housing instability and homelessness among rural schizophrenic patients

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022145125499

1 reference

19 April 2018

Dimensions Publication ID

1003241705

0 references

1 reference

19 April 2018